Public information

Autism medication in Ontario: what is used, what it treats, what OHIP and ODB cover

First question

What is changing?

Describe the symptom, its impact, what has been tried, and any safety concern.

Before a change

Confirm the plan

Ask what to monitor, when to review, and which effects need prompt attention.

No medication treats autism itself; medicines are sometimes used for co-occurring concerns such as irritability, ADHD, anxiety or sleep. OHIP+ covers medicines on the Ontario Drug Benefit formulary for eligible people 24 and under, and ODB covers eligible groups, so check your coverage and talk to your prescriber before starting, changing or stopping anything.

Ontario: OHIP+ · Ontario: Ontario Drug Benefit · Health Canada: Drug Product Database · Verified 2026-10-14

Date:

What Medication Can and Cannot Do

Understanding the role of medication in autism care is essential before starting any prescription. Medication may be used alongside behavioural, communication, or other supports when a qualified prescriber considers it appropriate.

What Medication Can Help With

  • May help with irritability or unsafe behaviours for some people
  • May help with attention or impulsivity when ADHD symptoms are present
  • May be considered for anxiety, panic, sleep, or obsessive-compulsive symptoms
  • May support mood symptoms when a co-occurring mood disorder is assessed
  • May make other supports more accessible for some people; response varies

What Medication Cannot Do

  • Treat or cure autism itself, no such medication exists
  • Replace behavioural therapy, OT, speech therapy, or other supports
  • Improve social skills or communication directly
  • Eliminate sensory processing differences
  • Work as a long-term standalone solution without regular review
  • Be changed or stopped without a prescriber-led follow-up plan
  • Guarantee the same response in every individual, effects vary widely

Common Medications by Target Symptom

The following medications are commonly used in Ontario for autistic individuals. This is not a complete list. Prescribing decisions are individualized based on the person's specific symptoms, medical history, and other factors.

Irritability, Aggression & Self-Injury

Antipsychotics (Atypical)

Some products in this class have product-specific regulatory indications; confirm the current monograph and target symptom with the prescriber.

Risperidone (Risperdal)

  • Product-specific indication and age limits vary; check the current monograph
  • May be considered for irritability-related symptoms after clinical assessment
  • Available as tablet, liquid, and orally dissolving tablet
  • Common side effects: weight gain, sedation, increased appetite
  • Ask the prescriber which metabolic monitoring is appropriate

Aripiprazole (Abilify)

  • Product-specific indication and age limits vary; check the current monograph
  • Side-effect profiles differ; discuss risks and monitoring with the prescriber
  • May cause restlessness (akathisia) in some individuals
  • Available as tablet and liquid formulation
  • Common side effects: weight gain, sedation, increased appetite

ADHD Symptoms: Attention, Impulsivity, Hyperactivity

ADHD Medications

ADHD may co-occur with autism (see autism and ADHD together). Stimulants and non-stimulants are both used, though response and side effects vary by person and should be reviewed with a prescriber.

Methylphenidate (Ritalin, Biphentin, Concerta)

Stimulant
  • First-line for ADHD symptoms in many cases
  • Immediate and extended-release formulations available
  • Ask the prescriber when and how effects will be reviewed
  • Side effects: appetite suppression, sleep difficulties, irritability

Guanfacine (Intuniv)

Non-Stimulant
  • Extended-release alpha-2 agonist
  • Useful when stimulants cause significant side effects
  • Review timing varies; follow the prescriber’s plan
  • Side effects: sedation, low blood pressure

Atomoxetine (Strattera)

Non-Stimulant
  • Non-controlled substance; preferred in some situations
  • Review timing varies; follow the prescriber’s plan
  • Side effects: nausea, appetite changes, mood changes
  • Ask the prescriber how to stop safely; do not change the prescription independently

Anxiety, OCD & Depression

SSRIs and Anxiolytics

Anxiety and obsessive-compulsive symptoms may co-occur with autism. The decision and monitoring plan should be individualized with a prescriber.

SSRIs (Selective Serotonin Reuptake Inhibitors)

  • Fluoxetine (Prozac)
  • Sertraline (Zoloft), commonly prescribed for anxiety and OCD
  • Escitalopram (Cipralex), well-tolerated, used for anxiety
  • Review timing varies; follow the prescriber’s plan
  • Ask the prescriber how to stop safely; do not change the prescription independently
  • Some people experience increased agitation or activation when starting; ask the prescriber how this should be monitored

Other Anxiolytics

  • Buspirone, non-habit-forming option for generalized anxiety
  • Clonidine, alpha-2 agonist; used for anxiety, sleep, and ADHD
  • Melatonin, used for sleep onset difficulties
  • Hydroxyzine, antihistamine used short-term for acute anxiety
  • Benzodiazepines, generally avoided long-term due to tolerance and dependence risk
  • Propranolol, sometimes used for performance anxiety or activation

Monitoring and Safety

Safe medication use requires a prescriber-led plan for expected effects, side effects, interactions, and follow-up. The appropriate checks depend on the person, medication, dose, and treatment goal.

Antipsychotic Monitoring (Risperidone / Aripiprazole)

  • Before starting: Ask which health history, measurements, laboratory checks, or movement assessments are appropriate for this medication
  • During treatment: Agree on what to monitor, which side effects need prompt attention, and how results will be shared
  • At follow-up: Review response, side effects, dose, interactions, and whether continuing remains appropriate with the prescriber

ADHD Medication Monitoring

  • Before starting: Ask which health history, measurements, and symptom measures are appropriate for this medication
  • After a change: Agree on how to review symptom response, side effects, interactions, and any dose change
  • At follow-up: Review growth, blood pressure, symptoms, and whether continuing remains appropriate with the prescriber

Source: Canadian Paediatric Society, ADHD in children and youth: Part 3 (2018, reaffirmed 2024)

Ontario Drug Coverage Programs

Ontario has several programs that cover prescription medication costs. Eligibility depends on age, income, and existing drug benefit coverage.

Access and coverage

Confirm the current route

Access to developmental pediatrics varies by region and referral route. Confirm the current intake estimate directly. Coverage depends on the medication, eligibility, and current program rules. Use the official links below to confirm the formulary and application requirements.

Ontario prescription coverage programs, eligibility and coverage details. Confirm current rules using the official source in each row. Page content reviewed 2026-10-14.
ProgramWho and what it coversDetailsSource
OHIP+Ontario Health Insurance Plan (Under 25)Covers most prescription drugs on the Ontario Drug Benefit formulary at no cost for Ontarians under 25 who do not have another drug benefit plan.
  • No deductible or co-pay for eligible individuals
  • Must not have employer or private drug coverage
  • Covers most common autism-related medications
OHIP+: Learn More
ODBOntario Drug Benefit ProgramCovers prescription drugs for eligible groups including Ontario Works recipients, ODSP recipients, Trillium Drug Program registrants, and others.
  • Co-pay and prior-approval rules depend on the eligibility category
  • Some medications require prior approval (Limited Use)
  • Eligibility through ODSP, OW, or Trillium
ODB: Learn More
TrilliumTrillium Drug ProgramHelps Ontario residents of any age with high drug costs relative to their household income.
  • Deductible depends on household income and current program rules
  • No age limit, available to all Ontario residents
  • After deductible met, ODB covers the rest of the year
Trillium: Learn More

Working with Your Prescriber

In Ontario, several types of medical professionals can prescribe medications for autism-related conditions. Building a collaborative relationship with your prescriber makes it easier to review goals, benefits, side effects, and next steps.

Types of Prescribers in Ontario

Developmental Pediatrician
Most specialized for autism medication management. Conducts formal assessments and coordinates care. Ask the centre about current referral and intake conditions.
Child and Adolescent Psychiatrist
Specializes in mental health co-occurring conditions. Can manage complex medication regimens and provide psychiatric assessment. Access through hospital outpatient or community programs.
Pediatrician
Can manage first-line medications (ADHD medications, melatonin) and refer to specialists for complex needs. Most accessible.
Family Physician
Can initiate and manage straightforward medications with specialist guidance. Comfort level with autism medications varies significantly.

Questions to Ask Your Prescriber

  • What condition are we targeting with this medication?
  • What is the expected timeline to see if it is working?
  • What are the most common side effects I should watch for?
  • What monitoring tests will be needed and how often?
  • What is the plan if this medication does not work or causes side effects?
  • Is this medication covered by OHIP+ or ODB?
  • If stopping is considered, what follow-up plan is needed?
  • How does this interact with any other medications my child takes?

Frequently Asked Questions

No. There is currently no medication that treats the core features of autism. Medications may be prescribed for co-occurring conditions such as anxiety, ADHD, irritability, sleep difficulties, or obsessive-compulsive behaviours. Product-specific approvals and age limits should be checked in the current Health Canada monograph with a prescriber.

Coverage depends on the medication and your family's eligibility. OHIP+ covers medications on the Ontario Drug Benefit formulary at no cost for people 24 and under who have OHIP and no private drug plan. The Ontario Drug Benefit (ODB) program covers eligible groups including people on ODSP and Ontario Works. The Trillium Drug Program helps eligible households with high drug costs relative to income. Check ontario.ca for the current formulary and program rules.

Risperidone can have side effects including weight or appetite changes, sedation, prolactin changes, metabolic effects, and movement-related effects. Ask the prescriber which checks are appropriate and which symptoms need prompt attention.

Pediatricians, developmental pediatricians, child and adolescent psychiatrists, and family physicians may prescribe medications for autism-related conditions within their scope. Ask about current access, referral rules, and when specialist input is needed. Some families access psychiatry through hospital outpatient programs, community programs, or telehealth options.

The review schedule and expected effects vary by medication, dose, person, and treatment goal. Ask the prescriber what to monitor, when to review, which side effects need urgent attention, and what would change the plan. Do not change or stop a prescription without prescriber guidance.

Your child's health

Find a Specialist and Access Support

Medication decisions work best alongside therapy and support. Our provider directory can help you find developmental pediatricians, psychiatrists, and other specialists across Ontario.

Guides and tools related to this page.

Sources on this page

The source chain stays visible.

Key claims are paired with their source, evidence tier, and verification date so readers can inspect the public record directly.

Facts3
Sources2

1 in 50

According to the 2019 Canadian Health Survey on Children and Youth, about 1 in 50 children and youth aged 1 to 17 in Canada had an autism diagnosis

Primary sourcePublic Health Agency of Canada (2024)Verified 2024-03-26

WHO recommends accessible, community-based early interventions for children with autism. Timely evidence-based psychosocial interventions improve communication and social engagement

Primary sourceWorld Health Organization (2025)Verified 2025-09-17
Last system verification: 2026-08-10. Next scheduled update: 2026-11-05.

About this page

Check the author’s context, review method, and how to report an error.

Written by

Founder & Autism Advocate

Lived experience: Parent of autistic child navigating OAP system